To make blockbuster returns in the sharemarket, you’ve got to find the winners of tomorrow, not today.
Clarity Pharmaceuticals is a radiopharmaceuticals medical group which uses radiation to target cancers for diagnostic and treatment purposes. Its product offers radiation against cancer cells by injecting radioisotopes named Cu-64 and Cu-67 into a patient, with its targeted nature meaning it tends to have less chronic side effects than the current standard of care chemotherapy.
Excitement around LTR stock has seen it quadruple in value since its December 2023 IPO and management says its product, named Spontan, works faster as it’s inhaled as a nasal spray, so it gets into the bloodstream quicker. But even if it does get approval, it will face a hard slog selling its product against generic competition that retails for just $13.99 a dose at Chemist Warehouse.
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: FinancialReview - 🏆 2. / 90 Read more »